Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction

QJM: An International Journal of Medicine

Volumn 102, Issue 8, 2009, Pages 555-561

  Richardson, Tristan ^a   Baker, J ^a   Thomas, P W ^b   Meckes, C ^a   Rozkovec, A ^a   Kerr, D ^a,b  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b BOURNEMOUTH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; COFFEE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FLUID INTAKE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART RATE VARIABILITY; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PARASYMPATHETIC TONE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; ST SEGMENT ELEVATION;

EID: 67949104968     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp072     Document Type: Article

References (29)

1. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, et al Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994; 90:613-22.
2. Feldman T, Silver R. Gender differences and outcome of interventions for acute coronary syndromes. Cardiol Rev 2000; 8:240-7.
3. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95:2053-9.
4. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated level of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99:855-60.
5. Stein JH, Neumann A, Preston LM, Vandenberg BJ, Parrillo JE, Calvin JE, et al. Improved risk stratification in unstable angina: identification of patients at low risk for in-hospital cardiac events by admission echocardiography. Clin Cardiol 1998; 21:725-30.
6. Nørgaard BL, Andersen K, Dellborg M, Abrahamsson P, Ravkilde J, Thygesen K. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: Additional prognostic information from continuous ST segment monitoring. J Am Coll Cardiol 1999; 33 1519-27.
7. Patel DJ, Knight CJ, Holdright DR, Mulcahy D, Clarke C, Wright H, Purcell and K.M. Fox. Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST-segment monitoring. Eur Heart J 1998; 19:240-9.
8. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256-62.
9. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction. JAMA 2006; 295 1135-41.
10. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Coffee consumption and mortality after acute myocardial infarction. Am Heart J 2004; 147: 999-1004.
11. Pozzati A, Pancaldi GL, Di Pasquale G, Pinelli G, Bugiardini R. Transient sympathovagal imbalance triggers 'ischemic' sudden death in patients undergoing electrocardiographic Holter monitoring. J Am Coll Cardiol 1996; 27:847-52.
12. Kop WJ, Verdino RJ, Gottdiener JS, O'Leary T, Merz N, Krantz D. Changes in heart rate and heart rate variability before ambulatory ischemic events. J Am Coll Cardiol 2001; 38:742-9.
13. De Ferrari GM, Vanoli E, Schwartz PJ. Cardiac vagal acitvity, myocardial ischemia and sudden death. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia, W.B. Saunders, 1995:422-34.
14. Bonaduce D, Marciano F, Petretta M, Migaux ML, Morgano G, Bianchi V, et al. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 1994; 90:108-13.
15. Pousset F, Copie X, Lechat P, Jaillon P, Boissel JP, Hetzel M, et al Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol 1996; 15(77):612-7.
16. Richardson T, Rozkovec A, Thomas P, Ryder J, Meckes C, Kerr D. Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. Diabetes Care 2004; 27:1127-31.
17. Lundsberg LS. Caffeine consumption. In: Spiller GA, ed. Caffeine. Boca Raton (FL), CRC Press, 1998:199-224.
18. Natella F, Nardini M, Belelli F, Pignatelli P, Di Santo S, Ghiselli A, et al. Effect of coffee drinking on platelets: Inhibition of aggregation and phenols incorporation. Br J Nutr 2008; 100 1276-82.
19. Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, et al. GISSI-Prevenzione Investigators. Coffee consumption and risk of cardiovascular events after acute myocardial infarction. Results From the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione Trial. Circulation 2007; 116:2944-51.
20. Mukamal KJ, Hallqvist J, Hammar N, Ljung R, Géemes K, Ahlbom A, et al. Coffee consumption and mortality after acute myocardial infarction: The Stockholm Heart Epidemiology Program. Am Heart J 2009; 157: 495-501.
21. Sofi F, Conti AA, Gori AM, Eliana ML, Casini A, Abbate R, et al. Coffee consumption and risk of coronary heart disease: A meta-analysis. Nutr Metab Cardiovasc Dis 2007; 17: 209-23.
22. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Int Med 2008; 148:904-14.
23. Zhang WL, Lopez-Garcia E, Li TY, Hu FB, van Dam RM. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia 2009; 52:810-7.
24. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology for the redefinition of myocardial infarction. Eur Heart J 2000; 21 1502-13.
25. Task Force of the European Society of Cardiology & the North American Society of pacing and electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93:1043-65.
26. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42:652-8.
27. Manfrini O, Pizzi C, Trerè D, Fontana F, Bugiardini R. Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction. Eur Heart J 2003; 24:1560-6.
28. Verrier RL, Antzelevitch C. Autonomic aspects of arrhythmogenesis: The enduring and the new. Curr Opin Cardiol 2004; 19:2-11.
29. Quintana M, Storck N, Lindblad LE, Lindvall K, Ericson M. Heart rate variability as a means of assessing prognosis after acute myocardial infarction. A 3-year follow-up study. Eur Heart J 1997; 18 789-97.